Wednesday, February 18, 2026 2/18/2026

Translation fidelity as a modulator of hematopoietic stem cell fitness and longevity

Award Number: F31HL174164
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 04/01/2024
PERIOD OF PERFORMANCE END DATE: 03/31/2026

Group Awards By:

View Award Description

Translation fidelity as a modulator of hematopoietic stem cell fitness and longevity - PROJECT SUMMARY/ABSTRACT Hematopoietic stem cells (HSCs) give rise to all blood and immune cells throughout life. Aging HSCs exhibit diminished regenerative function, myeloid-biased differentiation, and clonal outgrowth, which contribute to compromised immunity and increased incidence of bone marrow (BM) failure, and hematological malignancies in the aged population. Recent findings demonstrated that HSCs require strict regulation of protein homeostasis (proteostasis) to maintain self-renewal potential, but this declines with age. Translation is the most error prone step in gene expression and is a prominent source of proteostasis dysfunction. Previous studies demonstrated that HSCs depend on lower protein synthesis rates to preserve proteostasis, and increasing protein synthesis diminishes proteome quality and impairs HSC function. This raises the possibility that HSCs depend on enhanced translation fidelity, and that increasing fidelity could mitigate age-related changes in proteostasis and declines in HSC function. Our central hypothesis is that young adult HSCs have higher translation fidelity compared to restricted progenitors and old adult HSCs, and interventions that enhance translation fidelity will improve HSC fitness and longevity. To directly test this hypothesis, I generated a fluorescence-based translation fidelity reporter mouse, and in Aim 1 I will compare translation fidelity in young and old HSCs and progenitors in vivo. To examine the impact of enhancing fidelity, I generated a mouse model with high-fidelity ribosomes (Rps23K60R/K60R). Using this model, I will test if enhancing translation fidelity protects HSCs from the proteostasis disrupting effects associated with increased protein synthesis in a Pten-deficient mouse model in vivo. In Aim 2, I will test if enhancing translation fidelity improves age-associated declines in HSC function by performing comprehensive hematopoietic analyses and competitive transplantation assays. I will also determine if enhancing translation fidelity extends HSC longevity in serial transplantation assays. Finally, I will extend preliminary RNA-sequencing data to confirm that enhancing translation fidelity promotes improved proteostasis maintenance in aging HSCs using a suite of single cell assays to quantify misfolded and unfolded protein. Collectively, these studies will determine if translation fidelity varies across cell types within the blood and is altered upon aging or in the presence of HSC disrupting pathogenic mutations. Research outcomes will reveal if modulating translation fidelity is a potential therapeutic strategy to enhance stem cell fitness in older adults.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $42,319 )
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Blood Diseases and Resources Research	002	2	8/30/2025	NON-COMPETING CONTINUATION	$42,319
2025	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Blood Diseases and Resources Research	000	1	6/13/2025	TERMINATION	$0
2025	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Blood Diseases and Resources Research	001	1	7/16/2025	OTHER REVISION	$0
														Subtotal = $42,319

Issue Date FY: 2024 ( Subtotal = $41,755 )
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Blood Diseases and Resources Research	000	1	3/12/2024	NEW	$40,475
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Blood Diseases and Resources Research	002	1	8/29/2024	NEW	$1,280
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Blood Diseases and Resources Research	001	1	3/12/2024	NEW	$0
														Subtotal = $41,755

Grand Total All Awards = $84,074

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Translation fidelity as a modulator of hematopoietic stem cell fitness and longevity

Award Number: F31HL174164

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 04/01/2024

PERIOD OF PERFORMANCE END DATE: 03/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer